From sample to insight in a clinically relevant timeframe.
epsilonDx is developing a rapid phenotypic diagnostic approach to assess how microorganisms respond to antibiotic treatment. Our goal is to provide actionable susceptibility information faster, helping clinicians make better-informed therapy decisions when time matters most.
